XML 134 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities:        
Net loss $ (8,528) $ (3,897) $ (7,232) $ (11,706)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expense 18 67 74 279
Share-based compensation 1,158 1,531 1,927 2,305
Amortization of operating lease right-of-use assets 418 408 548 513
Non-cash interest expense 854 53 39
Loss on settlement of convertible notes 358    
Other income (see Note 2) (200) (3,556) (3,556)
Amortization of debt discount 160    
Change in fair value of forward purchase agreement asset 23 339
Change in fair value of SEPA put rights asset (55) 312
Change in fair value of embedded derivative liability 773 11
Gain on extinguishment of accrued liabilities     (173)
Changes in operating assets and liabilities:        
Accounts receivable (183) (235) 1,942
Prepaid expenses and other current assets (257) (93) (98) 84
Note receivable     4
Accounts payable 787 325 (860) (743)
Accrued expenses (73) 551 383 484
Income taxes payable (366) 57
Deferred revenue     (64)
Operating lease liability (456) (421) (566) (500)
Net cash used in operating activities (5,386) (5,215) (9,030) (7,402)
Cash Flows from Investing Activities:        
Purchase of property and equipment     (48)
Proceeds from sales of property and equipment 26    
Net cash provided by investing activities 26    
Cash Flows from Financing Activities:        
Proceeds from settlement of Forward Purchase Agreement 132    
Proceeds from issuances of debt 1,840 4,877    
Proceeds from issuance of Note payable 553    
Payments on Note payable (553)    
Issuance of Advance Shares 739    
Net proceeds from the Merger     490
Net proceeds from PIPE financing     10,361
Cash transferred into escrow pursuant to Forward Purchase Agreement     (1,134)
Proceeds from issuance of notes payable - related party     5,883 1,442
Payment of notes payable - related party     (5,735)
Proceeds from issuance of Convertible Notes, net of issuance costs     2,755
Payment of offering costs (365) (1,442) (371)
Repayment of finance lease liabilities (17) (17) (222)
Net cash provided by financing activities 2,711 4,495 11,161 849
Net change in cash and restricted cash (2,649) (720) 2,131 (6,601)
Cash and restricted cash - beginning of period 2,992 861 861 7,462
Cash and restricted cash - end of period 343 141 2,992 861
Supplemental disclosure of cash flow information and non-cash transactions:        
Interest paid 21 1 1 16
Offering costs included in accounts payable     436 507
Issuance costs for Advance Shares included in accrued expenses 51    
Fair value of common stock issued for services 161    
Common stock issued in settlement of convertible notes and embedded derivative liability 5,937    
Deferred offering costs included in accounts payable 575    
Reclassification of residual value guarantees under finance lease to accrued expense 113 113
Settlement of bonus accrual through notes payable - related parties     300
ACAB liabilities assumed in the Merger, net     6,585
Conversion of notes payable-related parties into common stock of New Abpro     2,000
Conversion of pre-merger preferred stock of Abpro into common stock of New Abpro     75,563
SEPA commitment fee paid in common stock shares     327
As reported within the unaudited condensed consolidated balance sheets:        
Cash 328 1 2,850 723
Restricted cash 15 140 142 138
Total cash and restricted cash as presented in the balance sheet $ 343 $ 141 $ 2,992 $ 861